Biren Amin
Stock Analyst at Piper Sandler
(1.85)
# 3,039
Out of 4,732 analysts
49
Total ratings
34.09%
Success rate
-7.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Initiates: Overweight | $74 | $32.65 | +126.65% | 1 | Dec 2, 2024 | |
| CRBP Corbus Pharmaceuticals Holdings | Initiates: Overweight | $35 | $11.92 | +193.62% | 1 | Dec 2, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Overweight | $200 → $182 | $118.00 | +54.24% | 5 | Nov 27, 2024 | |
| IMNM Immunome | Maintains: Overweight | $23 → $21 | $9.99 | +110.21% | 3 | Nov 14, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Overweight | $11 → $9 | $1.82 | +394.51% | 2 | Nov 14, 2024 | |
| ACLX Arcellx | Maintains: Overweight | $91 → $115 | $66.48 | +72.98% | 2 | Nov 8, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $40 → $32 | $29.94 | +6.90% | 2 | Nov 6, 2024 | |
| BBIO BridgeBio Pharma | Initiates: Overweight | $46 | $33.79 | +36.13% | 1 | Sep 4, 2024 | |
| CRGX CARGO Therapeutics | Maintains: Overweight | $37 → $34 | $12.39 | +174.41% | 2 | Aug 13, 2024 | |
| AGEN Agenus | Downgrades: Hold | $7 → $3 | $3.48 | -13.79% | 1 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $3.27 | +511.62% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $8.01 | +87.27% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.71 | +1,305.88% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $70 | $2.24 | +3,025.00% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $0.49 | +10,244.83% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $4.84 | +395.87% | 1 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $1.53 | +2,122.22% | 1 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,050 → $500 | $7.25 | +6,796.55% | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.35 | +161.68% | 1 | Jul 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $657 → $691 | $681.58 | +1.38% | 2 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $10 | $0.84 | +1,090.48% | 1 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $8.35 | - | 4 | Dec 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $101 | $15.85 | +537.22% | 1 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $143.26 | -51.84% | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $422.00 | -63.27% | 5 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $136 | $2.23 | +5,998.65% | 4 | Mar 6, 2017 |
Viking Therapeutics
Dec 2, 2024
Initiates: Overweight
Price Target: $74
Current: $32.65
Upside: +126.65%
Corbus Pharmaceuticals Holdings
Dec 2, 2024
Initiates: Overweight
Price Target: $35
Current: $11.92
Upside: +193.62%
Sarepta Therapeutics
Nov 27, 2024
Maintains: Overweight
Price Target: $200 → $182
Current: $118.00
Upside: +54.24%
Immunome
Nov 14, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $9.99
Upside: +110.21%
Allogene Therapeutics
Nov 14, 2024
Maintains: Overweight
Price Target: $11 → $9
Current: $1.82
Upside: +394.51%
Arcellx
Nov 8, 2024
Maintains: Overweight
Price Target: $91 → $115
Current: $66.48
Upside: +72.98%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Neutral
Price Target: $40 → $32
Current: $29.94
Upside: +6.90%
BridgeBio Pharma
Sep 4, 2024
Initiates: Overweight
Price Target: $46
Current: $33.79
Upside: +36.13%
CARGO Therapeutics
Aug 13, 2024
Maintains: Overweight
Price Target: $37 → $34
Current: $12.39
Upside: +174.41%
Agenus
Jul 19, 2024
Downgrades: Hold
Price Target: $7 → $3
Current: $3.48
Upside: -13.79%
Jun 21, 2024
Reiterates: Overweight
Price Target: $20
Current: $3.27
Upside: +511.62%
Jun 21, 2024
Maintains: Overweight
Price Target: $15
Current: $8.01
Upside: +87.27%
May 31, 2024
Initiates: Overweight
Price Target: $10
Current: $0.71
Upside: +1,305.88%
May 19, 2023
Maintains: Buy
Price Target: $120 → $70
Current: $2.24
Upside: +3,025.00%
Jan 11, 2021
Initiates: Buy
Price Target: $51
Current: $0.49
Upside: +10,244.83%
Oct 30, 2020
Initiates: Buy
Price Target: $24
Current: $4.84
Upside: +395.87%
Oct 19, 2020
Initiates: Buy
Price Target: $34
Current: $1.53
Upside: +2,122.22%
Sep 14, 2020
Downgrades: Hold
Price Target: $1,050 → $500
Current: $7.25
Upside: +6,796.55%
Jul 24, 2020
Initiates: Buy
Price Target: $14
Current: $5.35
Upside: +161.68%
Jun 12, 2020
Maintains: Buy
Price Target: $657 → $691
Current: $681.58
Upside: +1.38%
Jun 1, 2020
Downgrades: Hold
Price Target: $16 → $10
Current: $0.84
Upside: +1,090.48%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $8.35
Upside: -
Nov 9, 2017
Initiates: Buy
Price Target: $101
Current: $15.85
Upside: +537.22%
Oct 3, 2017
Maintains: Buy
Price Target: $66 → $69
Current: $143.26
Upside: -51.84%
Jul 11, 2017
Initiates: Buy
Price Target: $155
Current: $422.00
Upside: -63.27%
Mar 6, 2017
Initiates: Buy
Price Target: $136
Current: $2.23
Upside: +5,998.65%